A novel peptide blocking cancer cell invasion by structure-based drug design
Yuki Yamada(Nihon University), Hiroshi Kobayashi(Mayo Clinic in Arizona)
Cited by 4
Related Papers
The HNF-1β―USP28―Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma
|Oncotarget|2018|33
GSK‑3β mediates the effects of HNF‑1β overexpression in ovarian clear cell carcinoma
|Experimental and Therapeutic Medicine|2020|6
(Epi)genetic and clinical characteristics in 84 patients with pseudohypoparathyroidism type 1B
|European Journal of Endocrinology|2023|4